Gene · 7409
Papers3,486
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,486
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration. | J Biol Chem | 2020 | 32561640 | PubTator, text mining | PubMed |
| Cohen Syndrome Patient iPSC-Derived Neurospheres and Forebrain-Like Glutamatergic Neurons Reveal Reduced Proliferation of Neural Progenitor Cells and Altered Expression of Synapse Genes. | J Clin Med | 2020 | 32560273 | PubTator, text mining | PubMed |
| Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancer. | Clin Epigenetics | 2020 | 32552862 | PubTator, text mining | PubMed |
| Identification of Early Warning Signals at the Critical Transition Point of Colorectal Cancer Based on Dynamic Network Analysis. | Front Bioeng Biotechnol | 2020 | 32548109 | PubTator, text mining | PubMed |
| Idiopathic CD4 Lymphocytopenia: Current Insights. | Immunotargets Ther | 2020 | 32548074 | PubTator, text mining | PubMed |
| Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies. | Stem Cell Res Ther | 2020 | 32546200 | PubTator, text mining | PubMed |
| Active RAC1 Promotes Tumorigenic Phenotypes and Therapy Resistance in Solid Tumors. | Cancers (Basel) | 2020 | 32545340 | PubTator, text mining | PubMed |
| CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma. | J Hematol Oncol | 2020 | 32532329 | PubTator, text mining | PubMed |
| Morpho-Orthographic Complexity in Affix Spelling in Hebrew: A Novel Psycholinguistic Outlook Across the School Years. | Front Psychol | 2020 | 32528348 | PubTator, text mining | PubMed |
| Prenatal exposure to bisphenol A alters the transcriptome-interactome profiles of genes associated with Alzheimer's disease in the offspring hippocampus. | Sci Rep | 2020 | 32528016 | PubTator, text mining | PubMed |
| The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment. | Cells | 2020 | 32526891 | PubTator, text mining | PubMed |
| The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses. | Front Immunol | 2020 | 32499786 | PubTator, text mining | PubMed |
| Recent Advances in the Molecular Biology of Systemic Mastocytosis: Implications for Diagnosis, Prognosis, and Therapy. | Int J Mol Sci | 2020 | 32498255 | PubTator, text mining | PubMed |
| m6A Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses during Hematopoietic Development. | Immunity | 2020 | 32497523 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing identifies novel cell types in Drosophila blood. | J Genet Genomics | 2020 | 32487456 | PubTator, text mining | PubMed |
| Dephosphorylation of cGAS by PPP6C impairs its substrate binding activity and innate antiviral response. | Protein Cell | 2020 | 32474700 | PubTator, text mining | PubMed |
| Vav1 is Essential for HIF-1α Activation via a Lysosomal VEGFR1-Mediated Degradation Mechanism in Endothelial Cells. | Cancers (Basel) | 2020 | 32471123 | PubTator, text mining | PubMed |
| Machine learning-aided quantification of antibody-based cancer immunotherapy by natural killer cells in microfluidic droplets. | Lab Chip | 2020 | 32458907 | PubTator, text mining | PubMed |
| Pleiotropic Roles of Calmodulin in the Regulation of KRas and Rac1 GTPases: Functional Diversity in Health and Disease. | Int J Mol Sci | 2020 | 32456244 | PubTator, text mining | PubMed |
| Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development. | Exp Mol Med | 2020 | 32439954 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7409/papers?page=51